Phase II Study of Intravenous Vinorelbine in Patients With Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer
Trial Number
NCT03188159 (ClinicalTrials.gov Identifier)Contact Person
Status
Recruiting
Disease Site
Fallopian Tube & Ovarian
Lead Cooperative Group
Participating Groups
ANZGOG